For research and educational purposes only. Not medical advice.
Goralatide Reference
Educational, not medical advice reference for Goralatide: Recovery, Longevity; regulatory status, evidence posture, source review, and schedule…
Reference summary
Published work is mostly preclinical, focused on antifibrotic activity in cardiac, pulmonary, and renal models. Clinical antifibrotic programs have been small and exploratory.
Regulatory and posture
- Categories
- Recovery, Longevity
- Aliases
- Ac-SDKP, N-acetyl-Seryl-Aspartyl-Lysyl-Proline
- Evidence posture
- preclinical - Mostly rodent antifibrotic data. Human clinical antifibrotic programs are exploratory and small. No FDA-approved indication.
- Regulatory status
- No FDA-approved Ac-SDKP / goralatide drug label. Ac-SDKP is the natural N-terminal tetrapeptide cleaved from thymosin beta-4 and has been studied as an antifibrotic and hematopoietic regulator.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed search: Ac-SDKP (goralatide) antifibrotic tetrapeptide literature
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.